Given the fact that breast cancer cells and tumors secrete significant amounts of exosomes, we hypothesize that exo-AnxA2 from AA TNBC patients will have higher amounts of exo-AnxA2 secreted in their serum which contributes to the aggressiveness of their disease. The gene discussed is ANXA2; the disease is breast cancer.